Page last updated: 2024-09-03

n(6)-carboxymethyllysine and Atherosclerosis

n(6)-carboxymethyllysine has been researched along with Atherosclerosis in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (18.75)29.6817
2010's10 (62.50)24.3611
2020's3 (18.75)2.80

Authors

AuthorsStudies
Cai, Q; Fang, F; Ji, Y; Li, Y; Liu, W; Zhang, W1
Bao, Z; Geng, Y; Jing, L; Li, L; Pang, Q; Shao, C; Sun, Z; Wang, Z; Yan, J; Zhang, L1
Arai, T; Hoshi, T; Nishio, T; Nogami, M; Toukairin, Y1
Bao, Z; Dai, Z; Jing, L; Li, L; Shao, C; Sun, Z; Wang, Z; Xu, S; Yan, J; Ye, F; Zhu, J1
Feskens, EJM; Hanssen, NMJ; Schalkwijk, CG; Scheijen, JLJM; Stehouwer, CDA; Van der Kallen, CJ; van Greevenbroek, MM1
Bengtsson, E; Blixt, O; Danielsson, L; Jansson, B; Nodin, B; Nordin Fredrikson, G; Persson, N; Risinger, C; Welinder, C; Wendel, U1
Chen, X; Li, L; Liang, Y; Liu, N; Wang, Z; Yan, J; Yuan, W1
Furuno, S; Kawakami, M; Kobayashi, Y; Muramatsu, M; Shirai, H; Takeuchi, M; Takino, J; Yamagishi, S1
Chambless, LE; Couper, DJ; Duncan, BB; Heiss, G; Hoogeveen, RC; Luft, VC; Pankow, JS; Schmidt, MI1
Bahn, G; Beisswenger, PJ; Howell, S; Reaven, PD; Saremi, A; Schwenke, DC1
Basta, G; Castagnini, M; De Caterina, R; Del Turco, S; Epistolato, MC; Righini, P; Sangiorgi, GM; Tanganelli, P1
Ang, A; Arab, L; Crasto, C; Dalal, M; Ferrucci, L; Jardack, P; Semba, RD; Talegawkar, S; Traber, MG1
An, Y; Chen, D; Jiang, Y; Liu, N; Ren, L; Wang, Z; Zhu, Y1
Matsui, J; Matsuki, K; Matsumura, K; Murakami, H; Suda, T; Tamasawa, N; Tanabe, J; Yamashita, M1
Machado, AP; Moysés, ZP; Nakandakare, ER; Passarelli, M; Pinto, RS; Quintão, EC1
Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR1

Other Studies

16 other study(ies) available for n(6)-carboxymethyllysine and Atherosclerosis

ArticleYear
Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.
    Computational intelligence and neuroscience, 2022, Volume: 2022

    Topics: Atherosclerosis; Biomarkers; Coronary Disease; Glycation End Products, Advanced; Humans; Lysine; Receptor for Advanced Glycation End Products

2022
N
    Journal of immunology research, 2020, Volume: 2020

    Topics: Amputation, Surgical; Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cells, Cultured; Diabetic Foot; Foam Cells; Humans; Lysine; Mice; Mice, Knockout; Proto-Oncogene Proteins c-vav; rac1 GTP-Binding Protein; Signal Transduction

2020
Immunohistochemistry of advanced glycation end product N
    BMC research notes, 2020, May-12, Volume: 13, Issue:1

    Topics: Adult; Aged; Atherosclerosis; Atrial Remodeling; Autopsy; Coronary Vessels; Female; Fibrosis; Forensic Pathology; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptides; Young Adult

2020
CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Cell Migration Inhibition; Cell Movement; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Foam Cells; Glycation End Products, Advanced; Lysine; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; RAW 264.7 Cells

2018
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
    Clinical nutrition (Edinburgh, Scotland), 2018, Volume: 37, Issue:3

    Topics: Aged; Atherosclerosis; Body Mass Index; Cohort Studies; Diabetes Mellitus; Diet; Female; Food Handling; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Ornithine; Waist Circumference

2018
A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
    PloS one, 2018, Volume: 13, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Atherosclerosis; Epitope Mapping; Female; Glycation End Products, Advanced; Humans; Lysine; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Protein Array Analysis

2018
Effects of Nε-carboxymethyl-Lysine on ERS-mediated apoptosis in diabetic atherosclerosis.
    International journal of cardiology, 2014, Apr-01, Volume: 172, Issue:3

    Topics: Animals; Apoptosis; Atherosclerosis; Blood Glucose; Blotting, Western; Cholesterol; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Glycation End Products, Advanced; Immunohistochemistry; Lysine; Male; Mice

2014
Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Antibodies; Atherosclerosis; Beverages; Biomarkers; Enzyme-Linked Immunosorbent Assay; Food Analysis; Glycation End Products, Advanced; Humans; Japan; Lysine; Risk Factors

2015
Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
    Diabetic medicine : a journal of the British Diabetic Association, 2016, Volume: 33, Issue:10

    Topics: Atherosclerosis; Case-Control Studies; Cohort Studies; Diabetes Mellitus; Diabetic Angiopathies; Female; Glycation End Products, Advanced; Humans; Incidence; Lysine; Male; Middle Aged; Risk Factors

2016
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
    Diabetes care, 2017, Volume: 40, Issue:4

    Topics: Aged; Atherosclerosis; Blood Glucose; Carotid Intima-Media Thickness; Cholesterol; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Oxidation-Reduction; Pyruvaldehyde; Triglycerides

2017
High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
    European journal of clinical investigation, 2009, Volume: 39, Issue:12

    Topics: Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Carotid Artery Diseases; Carotid Artery, Common; Carotid Stenosis; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Glycation End Products, Advanced; Humans; Immunohistochemistry; Linear Models; Lysine; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic

2009
Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
    European journal of clinical nutrition, 2012, Volume: 66, Issue:1

    Topics: Adult; Aged; Atherosclerosis; Diabetes Mellitus; Diet; Female; Glycation End Products, Advanced; Humans; Kidney Diseases; Lysine; Male; Middle Aged; Young Adult

2012
Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Atherosclerosis, 2012, Volume: 221, Issue:2

    Topics: Alkaline Phosphatase; Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Blotting, Western; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Line; Core Binding Factor Alpha 2 Subunit; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Disease Progression; Glucose; Immunohistochemistry; Injections, Intravenous; Lipoproteins, LDL; Lysine; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Staining and Labeling; Time Factors; Vascular Calcification

2012
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
    Diabetes research and clinical practice, 2013, Volume: 99, Issue:1

    Topics: Aged; Apolipoprotein A-I; Aryldialkylphosphatase; Atherosclerosis; Biological Transport; Biomarkers; Cell Line; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipoproteins, HDL; Lysine; Macrophages; Male; Middle Aged; Serum Amyloid A Protein

2013
Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
    The international journal of biochemistry & cell biology, 2006, Volume: 38, Issue:3

    Topics: Albumins; Animals; Atherosclerosis; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Enzyme Inhibitors; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Lysine; Macrophages, Peritoneal; Metformin; Mice

2006
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.
    Journal of inherited metabolic disease, 2007, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media

2007